Wenchao Wang

Beijing 100070, PR China
Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Azoxystrobin induces mitochondrial apoptosis by inhibiting cytochrome b Qo site of mitochondrial complex Ⅲ in oral leukoplakia cells and a mouse model.

Azoxystrobin induces mitochondrial apoptosis by inhibiting cytochrome b Qo site of mitochondrial complex Ⅲ in oral leukoplakia cells and a mouse model.

Journal: Archives of oral biology

Published: March 25, 2026

Photocatalytic Reduction of CO2 to C2H4 on Palladium-Iron-Loading Phosphorus via Promoting C-C Linking and Suppressing CO Generation.

Photocatalytic Reduction of CO2 to C2H4 on Palladium-Iron-Loading Phosphorus via Promoting C-C Linking and Suppressing CO Generation.

Journal: ACS nano

Published: November 24, 2025

Repurposing of clinical-stage FLT3 inhibitor HYML-122 as a potent RIPK2 inhibitor for the treatment of inflammatory bowel disease.

Repurposing of clinical-stage FLT3 inhibitor HYML-122 as a potent RIPK2 inhibitor for the treatment of inflammatory bowel disease.

Journal: International immunopharmacology

Published: February 10, 2025

Timosaponin AIII enhances CAR-T cell potency and prevents relapse through impairing CAR-Tregs.

Timosaponin AIII enhances CAR-T cell potency and prevents relapse through impairing CAR-Tregs.

Journal: Nature communications

Published: January 24, 2025

Insensitivity of oncogenic EGFR R776L mutation to EGFR inhibitors in lung cancer.

Insensitivity of oncogenic EGFR R776L mutation to EGFR inhibitors in lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 31, 2023

Discovery of dihydropyridinone derivative as a covalent EZH2 degrader.

Discovery of dihydropyridinone derivative as a covalent EZH2 degrader.

Journal: European journal of medicinal chemistry

Published: July 26, 2023

Discovery of a highly potent pan-RAF inhibitor IHMT-RAF-128 for cancer treatment.

Discovery of a highly potent pan-RAF inhibitor IHMT-RAF-128 for cancer treatment.

Journal: European journal of pharmacology

Published: February 25, 2023

Structure-based discovery of IHMT-IDH1-053 as a potent irreversible IDH1 mutant selective inhibitor.

Structure-based discovery of IHMT-IDH1-053 as a potent irreversible IDH1 mutant selective inhibitor.

Journal: European journal of medicinal chemistry

Published: January 20, 2023

Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities.

Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities.

Journal: MedComm

Published: May 24, 2022

Multifactor Analysis of Costal Pain in Osteoporotic Fracture of Thoracic Vertebra.

Multifactor Analysis of Costal Pain in Osteoporotic Fracture of Thoracic Vertebra.

Journal: Pain physician

Published: September 23, 2021

Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2.

Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2.

Journal: Leukemia

Published: September 01, 2021

Extensive production of hydroxyl radicals during oxygenation of anoxic paddy soils: Implications to imidacloprid degradation.

Extensive production of hydroxyl radicals during oxygenation of anoxic paddy soils: Implications to imidacloprid degradation.

Journal: Chemosphere

Published: May 11, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026